Last updated 9 months ago

Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects

134 patients around the world
Available in Mexico
The objective is to know the effectiveness of combined treatment to maintain abstinence in participants with active smoking who are hospitalized in a reference center. Bupropion and nicotine replacement therapy are the drugs used in this clinical trial. Participants will be randomly assigned to two groups: nicotine replacement therapy or nicotine replacement therapy plus bupropion. All participants will have counseling, conductive behavioral therapy, follow-up at 3, 6 and 12 months with a pulmonologist. Pulmonary function tests will be performed every 3, 6, and 12 months. Abstinence will be corroborated with a cotinine (urine) test and an exhaled carbon monoxide test.
National Institute of Respiratory Diseases, Mexico
1Research sites
134Patients around the world

This study is for people with

Tobacco Use

Requirements for the patient

From 18 Years
All Gender

Medical requirements

>18 years
Active smokers (consumption of more than 100 cigarettes in their entire life, and who have consumed cigarettes in the last 30 days)
Hospitalized subjects
Informed consent
Subjects who have had pharmacological treatment to stop smoking in the last month
Subjects with contraindications for medications

Sites

Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
Recruiting
Calz. de Tlalpan 4502, Belisario Domínguez Secc 16, Tlalpan, Ciudad de México
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy